Synektik Spólka Akcyjna Logo

Synektik Spólka Akcyjna

SNT.WA

(3.0)
Stock Price

172,20 PLN

25.96% ROA

50.4% ROE

19.1x PER

Market Cap.

1.518.185.140,00 PLN

9.99% DER

1.7% Yield

12.84% NPM

Synektik Spólka Akcyjna Stock Analysis

Synektik Spólka Akcyjna Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Synektik Spólka Akcyjna Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (37.23%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a minimal amount of debt (22%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

6 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

7 Dividend

The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income.

8 Buffet Intrinsic Value

The company's stock seems undervalued (1.440) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

9 PBV

The stock's high Price-to-Book Value (P/BV) ratio (5.24x) suggests it's overvalued, potentially making it an expensive investment.

10 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

11 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

Synektik Spólka Akcyjna Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Synektik Spólka Akcyjna Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Synektik Spólka Akcyjna Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Synektik Spólka Akcyjna Revenue
Year Revenue Growth
2010 31.026.571
2011 45.077.182 31.17%
2012 61.451.512 26.65%
2013 77.375.827 20.58%
2014 78.693.406 1.67%
2015 83.598.417 5.87%
2016 49.433.136 -69.11%
2017 62.936.490 21.46%
2018 105.323.138 40.24%
2019 134.786.623 21.86%
2020 125.386.200 -7.5%
2021 128.627.450 2.52%
2022 166.860.941 22.91%
2023 406.822.840 58.98%
2023 446.918.080 8.97%
2024 495.915.040 9.88%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Synektik Spólka Akcyjna Research and Development Expenses
Year Research and Development Expenses Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 599.344 100%
2016 0 0%
2017 0 0%
2018 13.188.148 100%
2019 7.057.095 -86.88%
2020 5.220.064 -35.19%
2021 6.142.343 15.02%
2022 10.222.664 39.91%
2023 17.767.320 42.46%
2023 16.023.779 -10.88%
2024 32.278.680 50.36%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Synektik Spólka Akcyjna General and Administrative Expenses
Year General and Administrative Expenses Growth
2010 571.097
2011 824.540 30.74%
2012 4.727.674 82.56%
2013 7.725.633 38.81%
2014 6.366.849 -21.34%
2015 6.385.097 0.29%
2016 6.989.060 8.64%
2017 6.832.400 -2.29%
2018 9.737.818 29.84%
2019 9.288.809 -4.83%
2020 6.719.477 -38.24%
2021 6.780.954 0.91%
2022 9.519.889 28.77%
2023 13.184.080 27.79%
2023 13.755.267 4.15%
2024 14.026.200 1.93%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Synektik Spólka Akcyjna EBITDA
Year EBITDA Growth
2010 2.078.068
2011 -422.248 592.14%
2012 3.197.390 113.21%
2013 13.611.471 76.51%
2014 9.482.584 -43.54%
2015 3.709.683 -155.62%
2016 4.194.094 11.55%
2017 6.059.190 30.78%
2018 9.652.547 37.23%
2019 17.775.119 45.7%
2020 18.600.568 4.44%
2021 18.533.951 -0.36%
2022 19.078.332 2.85%
2023 97.086.920 80.35%
2023 83.953.010 -15.64%
2024 97.944.200 14.28%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Synektik Spólka Akcyjna Gross Profit
Year Gross Profit Growth
2010 10.354.339
2011 11.620.558 10.9%
2012 17.484.010 33.54%
2013 32.283.760 45.84%
2014 16.081.221 -100.75%
2015 9.839.865 -63.43%
2016 10.483.129 6.14%
2017 14.535.940 27.88%
2018 23.696.260 38.66%
2019 32.593.842 27.3%
2020 30.658.411 -6.31%
2021 30.265.284 -1.3%
2022 48.505.458 37.6%
2023 132.034.080 63.26%
2023 131.783.090 -0.19%
2024 172.188.600 23.47%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Synektik Spólka Akcyjna Net Profit
Year Net Profit Growth
2010 1.063.660
2011 -1.420.762 174.87%
2012 -644.941 -120.29%
2013 8.244.298 107.82%
2014 3.604.805 -128.7%
2015 -1.265.186 384.92%
2016 388.091 426%
2017 4.085.130 90.5%
2018 10.293.436 60.31%
2019 9.136.295 -12.67%
2020 8.810.134 -3.7%
2021 8.383.810 -5.09%
2022 10.301.206 18.61%
2023 54.061.000 80.95%
2023 52.452.190 -3.07%
2024 66.979.320 21.69%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Synektik Spólka Akcyjna Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2010 0
2011 0 0%
2012 0 0%
2013 1 100%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 1 100%
2019 1 0%
2020 1 0%
2021 1 0%
2022 1 100%
2023 6 83.33%
2023 6 0%
2024 8 14.29%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Synektik Spólka Akcyjna Free Cashflow
Year Free Cashflow Growth
2010 -2.155.648
2011 -8.001.166 73.06%
2012 -539.464 -1383.17%
2013 -14.735.046 96.34%
2014 -3.156.118 -366.87%
2015 -4.857.478 35.03%
2016 -15.042.864 67.71%
2017 7.880.640 290.88%
2018 2.850.394 -176.48%
2019 8.033.136 64.52%
2020 8.813.165 8.85%
2021 18.280.131 51.79%
2022 -16.405.348 211.43%
2023 -5.539.650 -196.14%
2023 84.795.541 106.53%
2024 3.145.578 -2595.71%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Synektik Spólka Akcyjna Operating Cashflow
Year Operating Cashflow Growth
2010 -1.017.710
2011 7.150.891 114.23%
2012 2.666.768 -168.15%
2013 6.431.592 58.54%
2014 11.962.263 46.23%
2015 5.722.563 -109.04%
2016 -8.061.648 170.99%
2017 14.571.640 155.32%
2018 5.224.438 -178.91%
2019 13.547.203 61.44%
2020 13.927.838 2.73%
2021 21.710.302 35.85%
2022 -6.183.782 451.08%
2023 -5.249.580 -17.8%
2023 93.089.670 105.64%
2024 15.832.981 -487.95%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Synektik Spólka Akcyjna Capital Expenditure
Year Capital Expenditure Growth
2010 1.137.937
2011 15.152.057 92.49%
2012 3.206.232 -372.58%
2013 21.166.638 84.85%
2014 15.118.381 -40.01%
2015 10.580.041 -42.9%
2016 6.981.216 -51.55%
2017 6.691.000 -4.34%
2018 2.374.044 -181.84%
2019 5.514.067 56.95%
2020 5.114.673 -7.81%
2021 3.430.171 -49.11%
2022 10.221.566 66.44%
2023 290.070 -3423.83%
2023 8.294.129 96.5%
2024 12.687.403 34.63%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Synektik Spólka Akcyjna Equity
Year Equity Growth
2010 3.358.775
2011 18.320.446 81.67%
2012 17.669.505 -3.68%
2013 55.927.916 68.41%
2014 58.328.915 4.12%
2015 56.546.937 -3.15%
2016 56.940.743 0.69%
2017 61.719.850 7.74%
2018 61.985.851 0.43%
2019 70.252.332 11.77%
2020 75.995.309 7.56%
2021 80.558.688 5.66%
2022 87.846.089 8.3%
2023 136.095.080 35.45%
2023 117.883.800 -15.45%
2024 171.357.040 31.21%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Synektik Spólka Akcyjna Assets
Year Assets Growth
2010 12.490.031
2011 50.466.163 75.25%
2012 61.563.561 18.03%
2013 105.112.805 41.43%
2014 106.793.578 1.57%
2015 104.404.344 -2.29%
2016 90.752.955 -15.04%
2017 115.232.610 21.24%
2018 108.586.537 -6.12%
2019 125.095.826 13.2%
2020 141.612.872 11.66%
2021 159.685.491 11.32%
2022 236.480.185 32.47%
2023 297.322.160 20.46%
2023 259.913.730 -14.39%
2024 350.556.650 25.86%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Synektik Spólka Akcyjna Liabilities
Year Liabilities Growth
2010 9.131.255
2011 32.145.717 71.59%
2012 43.894.056 26.77%
2013 49.184.888 10.76%
2014 48.464.663 -1.49%
2015 47.857.406 -1.27%
2016 33.812.212 -41.54%
2017 53.512.760 36.81%
2018 46.600.686 -14.83%
2019 54.843.494 15.03%
2020 65.617.562 16.42%
2021 79.126.802 17.07%
2022 148.634.095 46.76%
2023 146.030.480 -1.78%
2023 142.029.930 -2.82%
2024 179.199.610 20.74%

Synektik Spólka Akcyjna Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
72.54
Net Income per Share
9.32
Price to Earning Ratio
19.1x
Price To Sales Ratio
2.45x
POCF Ratio
13.19
PFCF Ratio
16.72
Price to Book Ratio
8.86
EV to Sales
2.36
EV Over EBITDA
11.86
EV to Operating CashFlow
12.67
EV to FreeCashFlow
16.06
Earnings Yield
0.05
FreeCashFlow Yield
0.06
Market Cap
1,52 Bil.
Enterprise Value
1,46 Bil.
Graham Number
64.9
Graham NetNet
-1.84

Income Statement Metrics

Net Income per Share
9.32
Income Quality
1.41
ROE
0.5
Return On Assets
0.23
Return On Capital Employed
0.5
Net Income per EBT
0.79
EBT Per Ebit
0.94
Ebit per Revenue
0.17
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.3
Operating Profit Margin
0.17
Pretax Profit Margin
0.16
Net Profit Margin
0.13

Dividends

Dividend Yield
0.02
Dividend Yield %
1.7
Payout Ratio
0.33
Dividend Per Share
3.03

Operating Metrics

Operating Cashflow per Share
13.49
Free CashFlow per Share
10.65
Capex to Operating CashFlow
0.21
Capex to Revenue
0.04
Capex to Depreciation
1.54
Return on Invested Capital
0.45
Return on Tangible Assets
0.26
Days Sales Outstanding
57.6
Days Payables Outstanding
75.3
Days of Inventory on Hand
22.96
Receivables Turnover
6.34
Payables Turnover
4.85
Inventory Turnover
15.9
Capex per Share
2.85

Balance Sheet

Cash per Share
8,99
Book Value per Share
20,09
Tangible Book Value per Share
14.89
Shareholders Equity per Share
20.09
Interest Debt per Share
2.01
Debt to Equity
0.1
Debt to Assets
0.05
Net Debt to EBITDA
-0.48
Current Ratio
1.48
Tangible Asset Value
0,13 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
182181270
Working Capital
0,07 Bil.
Intangibles to Total Assets
0.13
Average Receivables
0,09 Bil.
Average Payables
0,09 Bil.
Average Inventory
29383538.5
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Synektik Spólka Akcyjna Dividends
Year Dividends Growth
2020 0
2021 0 0%
2022 0 0%
2023 1 0%
2024 3 100%

Synektik Spólka Akcyjna Profile

About Synektik Spólka Akcyjna

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine; the development of IT solutions used in radiology; and produces and sells radiopharmaceutical products used in diagnostics for oncology. It also operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. In addition, the company offers maintenance services for medical equipment, as well as acceptance and specialist tests. Synektik Spólka Akcyjna was founded in 2001 and is based in Warsaw, Poland.

CEO
Mr. Cezary Dariusz Kozanecki
Employee
165
Address
ul. Józefa Piusa Dziekonskiego 3
Warsaw, 00-728

Synektik Spólka Akcyjna Executives & BODs

Synektik Spólka Akcyjna Executives & BODs
# Name Age
1 Mr. Cezary Dariusz Kozanecki
President of the Management Board & MD
70
2 Mr. Waldemar Wojciech Magnuszewski
Sales Director
70
3 Ms. Sawa Zuzanna Zarebinska
Secretary & Member of the Supervisory Board
70
4 Mr. Piotr Kaszuba
Head of Technology Laboratory and Laboratory Technical Manager
70
5 Mr. Jacek Krus
Deputy Administrative Director
70
6 Mr. Dariusz Marcin Korecki
Vice President of the Management Board
70
7 Ms. Katarzyna Debowska
Chief Accountant
70

Synektik Spólka Akcyjna Competitors

Selvita S.A. Logo
Selvita S.A.

SLV.WA

(2.0)
Ryvu Therapeutics S.A. Logo
Ryvu Therapeutics S.A.

RVU.WA

(0.5)
KRUK Spólka Akcyjna Logo
KRUK Spólka Akcyjna

KRU.WA

(2.5)
Auto Partner SA Logo
Auto Partner SA

APR.WA

(3.5)
ASBISc Enterprises Plc Logo
ASBISc Enterprises Plc

ASB.WA

(2.0)